Will Chiang

Will Chiang is a Senior Research Scientist specializing in Functional Genomics and Cell Gene Therapy at AstraZeneca, where they harness state-of-the-art technologies for drug target identification and validation. They hold a Ph.D. in Cancer Biology and Genome Editing from the University of Cambridge and previously contributed to innovative research at organizations like Immunocore and Base4. Will has published peer-reviewed work in Molecular and Cellular Biology and has a strong commitment to promoting Inclusion, Diversity, and Equity in the workplace. Their notable expertise includes developing cutting-edge CRISPR-Cas9 tools that have been widely adopted in research worldwide.